Targeting Interleukin-1 beta in high risk humans: Results from CANTOS
Peter Libby
Mallinckrodt Professor of Medicine, Harvard Medical School
Host: Christoph J. Binder
Targeting Interleukin-1 beta in high risk humans: Results from CANTOS
Peter Libby
Mallinckrodt Professor of Medicine, Harvard Medical School
Host: Christoph J. Binder